Results 101 to 110 of about 42,034 (235)

18F-FDG PET/MR Assessment of Pediatric Langerhans Cell Histiocytosis

International Journal of General Medicine, 2021
Jialing Niu,1,2 Jiangtao Liang,3 Qi Feng,2 Mei Wang,2 Luoyu Wang,4 Xiuhong Ge,2 Xiao Wang,5 Zhongxiang Ding2,6 1Zhejiang Chinese Medical University, Hangzhou, People’s Republic of China; 2Department of Radiology, Affiliated Hangzhou First People’s ...
Niu J, Liang J, Feng Q, Wang M, Wang L, Ge X, Wang X, Ding Z   +7 more
doaj  

F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in a Rare Case of Recurrent Malignant Mixed Mullerian Tumor

World Journal of Nuclear Medicine, 2014
We report a case of 66-year-old female with previous history of histopathologically proven. Malignant mixed mullerain tumor of the uterus in whom positron emission tomography/computed tomography (CT) done for characterization of soft tissue lesion in ...
Amit Bhoil, Raghava Kashyap, Anish Bhattacharya, Bhagwant Mittal   +3 more
doaj   +1 more source

Relationship between sex hormones levels and 18F-FDG uptake by the ovaries in premenopausal woman

Radiology and Oncology, 2019
The study was conducted to evaluate the effect of sex hormones on F-18 fluorodeoxyglucose (18F-FDG) uptake by normal ovaries.
Kim Tae Hee, Kim Mi Ran, Jung Yongsik, An Young-Sil   +3 more
doaj   +1 more source

Correlation between EGFR mutation status and F18‐fluorodeoxyglucose positron emission tomography‐computed tomography image features in lung adenocarcinoma

Thoracic Cancer, 2019
The purpose of this study was to investigate an association between EGFR mutation status ...
Lei Zhu, Guotao Yin, Wei Chen, Xiaofeng Li, Xiaozhou Yu, Xiang Zhu, Wei Jiang, Chaoyang Jia, P. Chen, Yufan Zhang, Dingyou Lu, Lijuan Yu, Xubin Li, Wengui Xu   +13 more
semanticscholar   +1 more source

The positron emission tomography with F18 17β-estradiol has the potential to benefit diagnosis and treatment of endometrial cancer [PDF]

, 2007
Background. The positron emission tomography (PET) with F18 17β-estradiol (FES) has good imaging for assessment of estrogen receptor in breast cancer. Case.
59650, 59651, 59652, 59653, 59654, 59655, 59656, FUJIBAYASHI, Yasuhisa, KOTSUJI, Fumikazu, KUROKAWA, Tetsuji, OKAZAWA, Hidehiko, SAWAMURA, Yoko, SHINAGAWA, Akiko, YOSHIDA, Yoshio   +13 more
core   +1 more source

Novel genetic assessments for cancer patients: where does medical imaging stand in the future of personalised medicine?

Journal of Medical Radiation Sciences, Volume 71, Issue 1, Page 7-9, March 2024.
As our understanding of genetics in cancer care improves, the role of personalised medicine for patients continues to grow. With the increasing emergence of novel technologies for patient assessment, such as the evaluation of circulating tumour DNA, we must reflect on the potentially changing role that medical imaging will play in the future of optimal
Sally L. Ayesa
wiley   +1 more source

Left ventricular dyssynchrony assessment by phase analysis from gated PET-FDG scans [PDF]

, 2018
Background: The outcome of patients with severe ischaemic left ventricular (LV) dysfunction is determined by the extent of myocardial viability and the presence of LV dyssynchrony.
Buechel, Ronny, Fiechter, Michael, Gaemperli, Oliver, Ghadri, Jelena-Rima, Herzog, Bernhard, Husmann, Lars, Kaufmann, Philipp, Küest, Silke, Nkoulou, Rene, Pazhenkottil, Aju, Wolfrum, Mathias   +10 more
core  

The prognostic value of F18 Fluorothymidine positron emission tomography for assessing the response of malignant pleural mesothelioma to chemotherapy – A prospective cohort study

Journal of Medical Imaging and Radiation Oncology, Volume 68, Issue 1, Page 57-66, February 2024.
Abstract Introduction Malignant pleural mesothelioma is difficult to prognosticate. F18‐Fluorodeoxyglucose positron emission tomography (FDG PET) shows promise for response assessment but is confounded by talc pleurodesis. F18‐Fluorothymidine (FLT) PET is an alternative tracer specific for proliferation.
Isaac J May, Anna K Nowak, Roslyn J Francis, Martin A Ebert, Satvinder S Dhaliwal   +4 more
wiley   +1 more source

Development of antibody‐drug conjugates in cancer: Overview and prospects

Cancer Communications, Volume 44, Issue 1, Page 3-22, January 2024.
Abstract In recent years, remarkable breakthroughs have been reported on antibody‐drug conjugates (ADCs), with 15 ADCs successfully entering the market over the past decade. This substantial development has positioned ADCs as one of the fastest‐growing domains in the realm of anticancer drugs, demonstrating their efficacy in treating a wide array of ...
Dan‐Yun Ruan, Hao‐Xiang Wu, Qi Meng, Rui‐Hua Xu   +3 more
wiley   +1 more source

Diagnostic Role of F-18 Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography in Restaging of Upper Urinary Tract Urothelial Carcinoma

Journal of Urological Surgery, 2017
Objective: To retrospectively evaluate contribution of F-18 fluorodeoxyglucose positron-emission tomography/computed tomography (18FDG-PET/CT) to re-staging of upper urinary tract urothelial carcinoma (UTUC). Materials and Methods: This study included a
Hakan Öztürk
doaj   +1 more source